GSKOther EquityGSKH · NYSE Arca

GSK plc ADRhedged (GSKH)

Compare Other Equity ETFs Compare with others

Price: $66.97; —11 Sept 2026
Assets: —; Total net assets
Expense ratio: 0.19%; Category 1.00%
Yield: —; Trailing distributions

1Y return: 18.9%+3.5%; Category 15.4%
3Y CAGR: —; Category 15.4%
5Y CAGR: —; Category 6.5%

Loading NAV history…

GSK plc ADRhedged

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-3.8%	-8.9%	-10.9%	-0.1%	+18.9%	—	—	—	+20.6%
Other Equity average	-1.6%	0.8%	11.5%	11.5%	15.4%	15.4%	6.5%	—	8.9%
Difference	-2.2%	-9.8%	-22.3%	-11.6%	+3.5%	—	—	—	+11.8%

Holdings

The 1 largest positions make up 98.9% of the fund.

Top holdings

Largest holdings by weight
Ticker	Holding	Weight
GSK	GSK PLC ADR	98.94%

Portfolio valuation

Weighted averages of what the fund holds.

P/E: 15.8
P/B: 4.2
P/S: 2.3
P/CF: 9.1

Sector allocation

Share of the equity the fund holds.

Health care100.0%

Asset mix

Stocks98.9%
Cash1.1%

ETF details

Issuer: GSK
Category: Equity · Other Equity
Ticker: GSKH
Exchange: NYSE Arca
Inception: 7 Jan 2025 (1.7 years)
Structure: Exchange Traded Fund
Expense ratio: 0.19% (category 1.00%)
Holdings turnover: 0% (category 51%)
Distribution yield: —
Total net assets: —

Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other other equity ETFs

Other ETFs in the Other Equity category.

Compare Other Equity ETFs